E106K (p.Glu106Lys) variant of ABL2 (Tyrosine-protein kinase ABL2)
E106K (p.Glu106Lys) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
E106K (p.Glu106Lys) variant details
- p.Glu106Lys
- NCI-TCGA Cosmic COSV1007
- cosmic curated COSV10077
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.